Health Care

Feb 25, 2013

Actavis gets FDA approval for new generic

Actavis Inc. said today it has received Food and Drug Administration approval of its abbreviated new drug application for its treatment for opioid dependence. The drug is the generic equivalent of Reckitt Benckiser's Suboxone.

Feb 25, 2013

Finding corrections for soaring health care costs

Health care executives often say implementing new models of care means having one foot in the old world of health care and another in the new. The transition is slow because of the difficulty of finding evidence that new models work in the real world, both to improve care and cut costs.

Feb 25, 2013

Hoping tax credit helps angels give startups wings

New Jersey hopes a new tax credit helps it become a hub for high-tech jobs across hot fields like bio-
technology, medical devices and renewable energy.

Feb 22, 2013

State continues quest to lower end-of-life care costs

Another tool has been added to the roster for decreasing the cost of end-of-life care and increasing compliance with patients' wishes.

Feb 22, 2013

Capsugel launches business unit to expand offerings

Capsugel, of Morristown, announced Thursday the launch of its Dosage Form Solutions business unit to focus on lipid-based formulations of its technology, while continuing to expand its offerings in targeted release capsules.

Feb 21, 2013

Eisai gets 65M for U.S. rights to Targretin

Eisai Inc.’s U.S. operations announced today that it sold the U.S. rights to its Targretin capsules and gel to Montreal-based Valeant Pharmaceuticals International Inc.

Feb 20, 2013

Insurers realize enormity of challenges posed by health exchanges

Experts say time is short for the government to build the technology to run and operate the exchange — and to educate thousands of individuals and small-business owners on how to shop for complex health insurance plans.

Feb 20, 2013

Celgene announces 600 million share repurchase program

Summit-based life sciences company Celgene Corp. announced today it is repurchasing $600 million in shares of its common stock through an accelerated repurchase agreement with an investment bank.

Feb 20, 2013

Merck partnering with S. Korean firm to develop biosimilars

Merck & Co., in the Whitehouse Station section of Readington, announced today an agreement with Samsung Bioepis Co. Ltd. to develop and commercialize several biosimilar candidates.

Feb 19, 2013

Terumo brings urology distribution in house

A New Jersey medical device firm is gearing up for expansion.

Feb 19, 2013

Savient partnering with Swedish firm to market arthritis treatment

Savient Pharmaceuticals Inc., in Bridgewater, announced today it is partnering with Sobi, of Stockholm, to promote Kineret, a treatment for rheumatoid arthritis, in the United States.

Feb 18, 2013

Holy Name recognized for care efforts in Haiti

When a devastating earthquake hit Haiti in 2010, Holy Name Medical Center was in a good position to help, as over the past two decades, it has built a presence at Hopital Sacre Coeur, in Milot, about a four-hour drive from Port-au-Prince.